Gujarat Kidney & Super Speciality Share Price

Gujarat Kidney shares rise 10% in trade; here's what's boosting rally?

Gujarat Kidney makes positive D-St debut; lists at 6% premium on bourses

Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve and take on record the Un-Audited standalone and consolidated Financial Results of the Company for the quarter ended December 31 2025 and any other business with the permission of the Chair.With reference to the earlier announcement dated February 10 2026 pursuant to the provisions of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 this is to inform you that due to unavoidable circumstances the Meeting of Board of Directors which was scheduled to be held on Friday February 13 2026 is now postponed and re-scheduled on Saturday February 14 2026.

Gujarat Kidney And Super Speciality Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2025 and any other business if any.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Thursday 5th February 2026 (which commenced at 3:30 p.m. and concluded at 4:30 .p.m.) inter alia has approved the following:-1) APPROVAL FOR TO MAKE INVESTMENT IN PATEL PHARMACY.2) APPROVAL FOR TO MAKE INVESTMENT IN PATEL MULTISPECIALITY HOSPITAL AND ICU.

Please find enclosed Certificate under Regulation 74(5) under SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December2025.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) read with Schedule III to the Listing Regulations this is to inform you that the Board of Directors of the Company at its Meeting held today i.e. on Tuesday 6th January 2025 (which commenced at 5:00 p.m. and concluded at 6:00 .p.m.) inter alia has approved the following:-1) APPROVAL FOR AQUIRE REMAINING 49% SHARES OF M/S. HARMONY MEDICARE PRIVATE LIMITED AND TO MAKE THEM AS WHOLLY OWNED SUBSIDIARY COMPANY.2) ACCORDING TO ACQUISITION AGREEMENT AND THE ACQUISITION AGREEMENT-II AND OBJECT OF THE ISSUE OF INITIAL PUBLIC OFFERING THE BOARD OF DIRECTORS APPROVED TO MAKE PART PAYMENT OF RS. 1240 LAKHS AS PURCHASE CONSIDERATION FOR THE ALREADY ACQUIRED ASHWINI MEDICAL CENTRE